TY  - GEN
AU  - Thompson,D S
AU  - Greco,A
AU  - Miller,A A
AU  - Srinivas,N R
AU  - Igwenezue,K B
AU  - Hainsworth,J D
AU  - Schacter,L P
AU  - Kaul,S
AU  - Barbhaiya,R H
AU  - Garrow,C
TI  - A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days
SN  - 0009-9236
PY  - 1995///0630
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Chromatography, High Pressure Liquid
KW  - Cohort Studies
KW  - Dose-Response Relationship, Drug
KW  - Etoposide
KW  - Female
KW  - Half-Life
KW  - Humans
KW  - Infusions, Intravenous
KW  - Leukopenia
KW  - chemically induced
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Organophosphorus Compounds
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1016/0009-9236(95)90034-9
ER  -